Market Share of Global Axial Spondyloarthritis (axSpA) Industry
The axial spondyloarthritis market is fragmented, competitive, and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Johnson & Johnson, UCB, Amgen, Novartis Pharmaceuticals Corporation, Eli Lilly and Company, Kyowa Kirin, AbbVie, Acelyrin, and Pfizer.
Axial Spondyloarthritis (axSpA) Market Leaders
Janssen Biotech
AbbVie
UCB
Amgen
Novartis Pharmaceuticals Corporation
*Disclaimer: Major Players sorted in no particular order
